Transgelin: An actin-binding protein and tumour suppressor

被引:215
作者
Assinder, Stephen J. [1 ,2 ]
Stanton, Jo-Ann L. [3 ]
Prasad, Priya D. [3 ]
机构
[1] Univ Sydney, Discipline Physiol, Sch Med Sci, Sydney, NSW 2006, Australia
[2] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia
[3] Univ Otago, Dept Anat & Struct Biol, Sch Med Sci, Dunedin, New Zealand
关键词
Transgelin; SM22; TGF-beta; MMP-9; Cancer; SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTORS; HUMAN SM22; IN-VIVO; SM22-ALPHA; EXPRESSION; GENE; CALPONIN; GROWTH; MICE;
D O I
10.1016/j.biocel.2008.02.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transgelin is a shape change sensitive 22 kDa actin-binding protein of the calponin family. It contains a C-terminal calponin-like module (CLIK'-;) and an upstream positively charged amino acid region required for actin binding. Transgelin is ubiquitous to vascular and visceral smooth muscle and is an early marker of smooth muscle differentiation, where its expression is driven by CArG box. smooth muscle gene promoter. It is also present in fibroblasts, and some epithelium where expression is likely driven by TGF-beta 1. Transgelin null mice reveal that, whilst it is not required for smooth muscle development, transgelin may be involved in calcium-independent smooth muscle contraction. Recent evidence suggests that transgelin acts as a tumour suppressor. Its expression is lost in prostate, breast and colon cancers. This is consistent with suppression of the metallo matrix protease-9 (MMP-9) by transgelin, where MMP-9 is upregulated in these common cancers. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:482 / 486
页数:5
相关论文
共 27 条
[21]   THE MADS-BOX FAMILY OF TRANSCRIPTION FACTORS [J].
SHORE, P ;
SHARROCKS, AD .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 229 (01) :1-13
[22]   Profiling molecular targets of TGF-β1 in prostate fibroblast-to-myofibroblast transdifferentiation [J].
Untergasser, G ;
Gander, R ;
Lilg, C ;
Lepperdinger, G ;
Plas, E ;
Berger, P .
MECHANISMS OF AGEING AND DEVELOPMENT, 2005, 126 (01) :59-69
[23]  
Wulfkuhle JD, 2002, CANCER RES, V62, P6740
[24]   Human SM22α BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stages [J].
Xu, R ;
Ho, YS ;
Ritchie, RP ;
Li, L .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (04) :H1398-H1407
[25]   Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor - Transactivation and prostate cancer cell growth [J].
Yang, Zhiming ;
Chang, Yu-Jia ;
Miyamoto, Hiroshi ;
Ni, Jing ;
Niu, Yuanjie ;
Chen, Zhaodian ;
Chen, Yuh-Ling ;
Yao, Jorge L. ;
di Sant'Agnese, P. Anthony ;
Chang, Chawnshang .
MOLECULAR ENDOCRINOLOGY, 2007, 21 (02) :343-358
[26]   Ablation of SM22α decreases contractility and actin contents of mouse vascular smooth muscle [J].
Zeidan, A ;
Swärd, K ;
Nordström, I ;
Ekblad, E ;
Zhang, JCL ;
Parmacek, MS ;
Hellstrand, P .
FEBS LETTERS, 2004, 562 (1-3) :141-146
[27]   Analysis of SM22α-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function [J].
Zhang, JCL ;
Kim, S ;
Helmke, BP ;
Yu, WW ;
Du, KL ;
Lu, MM ;
Strobeck, M ;
Yu, QC ;
Parmacek, MS .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (04) :1336-1344